Chargement en cours...
Development of a dosing strategy for enoxaparin in obese patients
AIMS: Enoxaparin dosing is currently based on total body weight. It is not known how to dose adjust for patients who are overweight or obese. This population pharmacokinetic pharmacodynamic (PKPD) study was undertaken to determine a suitable dosing strategy for such patients. METHODS: Patients admit...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Blackwell Science Inc
2003
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1884333/ https://ncbi.nlm.nih.gov/pubmed/12848781 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2003.01849.x |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|